Key result
TRIM7 restricts Coxsackievirus and norovirus infection by detecting and binding to a C-terminal helix-FQ motif generated by viral 3C protease processing, leading to substrate degradation.
Why the study?
TRIM7 ubiquitination of multiple substrates with unrelated biological functions is at odds with the specificity usually displayed by ubiquitin ligases, leaving its binding mechanism and cross-reactivity unexplained.
TRIM7 restricts certain RNA viruses by recognizing a C-terminal glutamine generated by viral 3C protease processing, revealing a novel mechanism of viral restriction.
May enable TRIM7-based protein degradation tools; leaves open therapeutic translation in cardiovascular disease.
TRIM7 catalyses the ubiquitination of multiple substrates with unrelated biological functions. This cross-reactivity is at odds with the specificity usually displayed by enzymes, including ubiquitin ligases. Here we show that TRIM7’s extreme substrate promiscuity is due to a highly unusual binding mechanism, in which the PRYSPRY domain captures any ligand with a C-terminal helix that terminates in a hydrophobic residue followed by a glutamine. Many of the non-structural proteins found in RNA viruses contain C-terminal glutamines as a result of polyprotein cleavage by 3C protease. This viral processing strategy generates novel substrates for TRIM7 and explains its ability to inhibit Coxsackie virus and norovirus replication. In addition to viral proteins, cellular proteins such as glycogenin have evolved C-termini that make them a TRIM7 substrate. The ‘helix-ΦQ’ degron motif recognised by TRIM7 is reminiscent of the N-end degron system and is found in ∼ 1% of cellular proteins. These features, together with TRIM7’s restricted tissue expression and lack of immune regulation suggest that viral restriction may not be its physiological function.
No takes yet. Share an insight, caveat, or question.
Lupták et al. (2022) studied Coxsackievirus and norovirus infection. TRIM7 vs. TRIM7 mutants (e.g., R385A) or empty vector was evaluated on Viral restriction (fraction of infected cells or viral replication by TCID50). TRIM7 restricts Coxsackievirus and norovirus infection by detecting and binding to a C-terminal helix-FQ motif generated by viral 3C protease processing, leading to substrate degradation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: